Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis-Reference-Cited by-同舟云学术

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis

Published:2021-07-19 Issue:7 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Komolafe Oluyemi¹,Buzzetti Elena²,Linden Audrey³,Best Lawrence MJ³,Madden Angela M⁴,Roberts Danielle³,Chase Thomas JG⁵,Fritche Dominic⁶,Freeman Suzanne C⁷,Cooper Nicola J⁷,Sutton Alex J⁷,Milne Elisabeth Jane⁸,Wright Kathy⁹,Pavlov Chavdar S¹⁰,Davidson Brian R³,Tsochatzis Emmanuel²,Gurusamy Kurinchi Selvan³¹⁰

Affiliation:

1. University College London; London UK

2. Sheila Sherlock Liver Centre; Royal Free Hospital and the UCL Institute of Liver and Digestive Health; London UK

3. Division of Surgery and Interventional Science; University College London; London UK

4. School of Life and Medical Sciences; University of Hertfordshire; Hatfield UK

5. Department of General Surgery; Homerton University Hospital NHS Foundation Trust; London UK

6. UCL Medical School; London UK

7. Department of Health Sciences; University of Leicester; Leicester UK

8. Centre for Trust, Peace and Social Relations; Coventry University; Coventry UK

9. Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

10. Department of Therapy; I.M. Sechenov First Moscow State Medical University; Moscow Russian Federation

Publisher

Wiley

Subject

Pharmacology (medical)

Reference407 articles.

1. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial;Abdelmalek;Hepatology (Baltimore, Md.),2009

2. The effects of bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial;Abhari;Clinical Nutrition ESPEN,2020

3. The effect of hydroalcoholic berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease;Afsharinasab;Saudi Journal of Biological Sciences,2020

4. Effect of beta vulgaris extract on liver enzymes in patients with non-alcoholic fatty liver disease: a randomized clinical trial;Afzali;Hepatitis Monthly,2020

5. Change of microbiota in patients with improved fatty liver and obesity;Ahn;Journal of Hepatology,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach;European Cardiology Review;2024-06-19

2. Is curcumin the new kid on the block for the treatment of MASH?;Hepatology;2024-05-28

3. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD);Obesity Facts;2024

4. Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat;Diabetic Medicine;2023-10-31

5. The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease;Medicine;2023-10-06